MEA Endovenous Laser Therapy Market

The size of the Middle East and Africa Endovenous Laser Therapy market was around USD 21.76 million in 2022. It is expected to grow at a CAGR of 7.4% to reach USD 31.09 million by 2027. It captures 8% of the global market. The growth of the MEA market is primarily expected to be driven by the factors such as the growing number of patients with varicose veins, the quick and effective technique, and the increasing demand for endovenous laser therapy.

A faster and more successful procedure for treating varicose veins than traditional vein surgery is another encouraging factor for the market to grow further during the forecast period. The treatment is performed under local anesthetic and causes only minor discomfort. Endovenous laser therapy usage increases in response to rising demand, resulting in increased revenue.

The expanding number of patients with varicose veins in the Middle East and Africa is also expected to be propelling the endovenous laser therapy market forward. Female patients have more pronounced varicose veins than male ones. Furthermore, an aging population is causing an increase in varicose veins, a frequent disease across the Middle East and Africa. Varicose veins can also be caused by a change in lifestyle that includes little physical activity.

Most crucially, pregnant women are at a greater risk of varicose veins, partially due to hormones generated during pregnancy that loosen vein walls and partly due to increased pressure on the veins caused by the baby. In addition, varicose veins can develop due to damage to a deep leg vein. Therefore, over the projection period, an increase in the number of patients with varicose veins is predicted to drive revenue growth for endovenous laser therapy.

However, manual errors and other undesirable faults, on the other hand, may hamper market expansion during the projection period. The high initial cost and high-risk factors associated with varicose veins treatment, on the other hand, are likely to limit the development of the endo-venous laser therapy market. At the same time, a scarcity of highly experienced professionals may also restrict the market's growth.

This research report on the Middle East and Africa endovenous laser therapy market has been segmented and sub-segmented into the following categories.

By Technology:

• Endovenous Laser Systems             
  • Diode Lasers
  • YAG Lasers
• Endovenous Laser Fibres  
  • Bare Tip Laser Fibre
  • Radial Tip Laser Fibre
  • Gold Tip Laser Fibre

By End User:

• Hospital   
• Clinic         
• Ambulatory Centre        

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East and Africa are expected to account for a moderate share in the global market during the forecast period. Varicose veins are becoming more common in adult populations in the Middle East and Africa as obesity rates rise. The UAE is predicted to expand because of the large number of patients suffering from varicose veins.

In addition, the UAE and Kuwait are likely to showcase a healthy CAGR due to the rapid shift in lifestyle with no physical activity and liver across the MEA and the aging population. The market is also expected to develop due to the quick and effective technique and the growing demand for endo-venous laser therapy.

KEY MARKET PLAYERS:

Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, AngioDynamics, Inc., Syneron Medical Ltd, Dornier Medtech GmbH, Wontech Co., Ltd, intros Medical Laser GmbH, Energist Ltd are expected to lead the MEA market during the forecast period.